Press Releases PYC Therapeutics Limited

Equities

Delayed Australian S.E. Other stock markets 08:54:46 2024-04-29 pm EDT			5-day change	1st Jan Change
0.093 ^AUD	+1.09%		-1.06%	-15.45%

Apr. 22	Australian Shares Rebound Amid Easing Middle East Tensions, Ahead of Local Inflation Data	MT
Apr. 22	PYC Therapeutics Confirms Safety, Tolerability of Kidney Medication in Animal Study	MT

PYC Therapeutics : Corporate Presentation - May 2022	22-05-30	PU
PYC Therapeutics : Q1 Investor Call Presentation	22-03-16	PU
PYC Therapeutics : Notification regarding unquoted securities - PYC	22-03-01	PU
PYC Therapeutics : Quarterly Activities and Appendix 4C Cash Flow Report	22-01-26	PU
PYC Therapeutics : Notification regarding unquoted securities - PYC	21-11-29	PU
PYC Therapeutics : 2021 AGM Chairman's Address and CEO Presentation	21-11-17	PU
Phylogica : Change of Director’s Interest Notice	19-04-24	PU
Phylogica : Scientific Advisory Board Appointment	19-03-22	PU
Phylogica : Collaboration Agreement – siRNA delivery	19-03-13	PU
Phylogica : CEO Letter and Operational Update	19-01-16	PU
Phylogica : In vivo success – peptide vaccine in Herpes Simplex Virus	18-12-06	PU
Phylogica : AGM Company Presentation	18-11-15	PU
Phylogica : R&D Tax Incentive Refund	18-10-08	PU
Phylogica : Reinstatement to Official Quotation	18-09-11	PU
Phylogica : Recapitalisation	18-09-11	PU
Phylogica : Trading Halt	18-09-06	PU
Phylogica : platform described in Nature – Scientific Reports	18-08-22	PU
Phylogica : Delivering Cancer Treatment Inside Cells – Nature Oncogene	18-08-05	PU
Phylogica : Achievement of Major Milestone – In vivo Cre Delivery	18-07-29	PU
Phylogica : Peer Reviewed Journal Publication	18-07-16	PU

No results for this search